Landfar Bio medicine Co

Landfar Bio medicine Co Book Value per Share

The Book Value per Share of Landfar Bio medicine Co (000504.SZ) as of Nov 4, 2026 is 0.81 CNY. In the previous year, Book Value per Share was 0.72 CNY — a change of 12.09% (higher).

Book Value per Share

0.81CNY

YoY

12.09%

Last updated:

Book Value per Share of Landfar Bio medicine Co is 2025 0.81 CNY. Book Value per Share of Landfar Bio medicine Co was 2024 0.72 CNY. It decreases by 12.09% higher compared to the previous year.

The Landfar Bio medicine Co Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value per Share
Date
Book Value per Share
Jan 1, 2018
-0.03 CNY
Jan 1, 2019
0.06 CNY
Jan 1, 2020
0.08 CNY
Jan 1, 2021
0.05 CNY
Jan 1, 2022
0.04 CNY
Jan 1, 2023
0.78 CNY
Jan 1, 2024
0.72 CNY
Jan 1, 2025
0.81 CNY
The Landfar Bio medicine Co Book Value per Share history
YEARBook Value per ShareYoY
0.81CNY+12.09%
0.72CNY-7.72%
0.78CNY+1,765.79%
0.04CNY-17.24%
0.05CNY-37.37%
0.08CNY+44.28%
0.06CNY-279.64%
-0.03CNY-141.60%
0.07CNY+367.39%
0.02CNY-131.94%
-0.05CNY-450.54%
0.01CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Landfar Bio medicine Co Stock analysis

What does Landfar Bio medicine Co do? NanHua Bio-medicine Co., Ltd. generates revenue through the manufacture and sale of pharmaceutical products, stem cell storage and technical services, stem cell treatment research, medical instrument purchasing and sales, as well as energy management company (EMC) contract energy management, build-transfer (BT), product sales, and sewage treatment. The company serves domestic customers seeking pharmaceuticals, stem cell services, medical instruments, and environmental solutions. Its biomedical segment focuses on stem cell-related offerings, while the energy conservation and environmental protection segment handles EMC, BT, and sewage treatment services. The firm operates exclusively within the domestic market, targeting businesses and consumers needing healthcare and environmental services. The company's revenue streams include pharmaceutical manufacturing, stem cell storage, medical instrument sales, and environmental services like EMC and BT projects. Domestic clients, including healthcare providers and environmental management firms, purchase these services and products. NanHua Bio-medicine Co., Ltd. leverages its domestic market presence to provide integrated solutions in healthcare and environmental sectors, with no international operations or external partnerships mentioned in its business description. Landfar Bio medicine Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Landfar Bio medicine Co stock

Book Value per Share of Landfar Bio medicine Co is 0.81 CNY in 2025.

Book Value per Share of Landfar Bio medicine Co changed from 0.72 CNY to 0.81 CNY, representing a 12.09% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Book Value per Share Landfar Bio medicine Co since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Landfar Bio medicine Co

All Key Metrics — Landfar Bio medicine Co